62 related articles for article (PubMed ID: 2511093)
1. Expression of the hybrid P210 bcr/abl protein in Philadelphia chromosome positive B-lymphoid cell lines.
Stacchini A; Ponzetto C; Guerrasio A; Martinotti G; Rege Cambrin G; Scaravaglio P; Rosso C; Piacibello W; Aglietta M; Saglio G
Haematologica; 1989; 74(3):249-54. PubMed ID: 2511093
[TBL] [Abstract][Full Text] [Related]
2. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
3. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
4. A Ph1 chromosome positive B cell line expresses the fusion protein P 210.
Munker R; Miller CW; Berenson J; Dreazen O; Koeffler HP
Nouv Rev Fr Hematol (1978); 1989; 31(1):39-43. PubMed ID: 2492656
[TBL] [Abstract][Full Text] [Related]
5. [Rearrangement and expression of bcr-abl genes in CML and ALL].
Kunieda Y; Okabe M
Rinsho Ketsueki; 1991 Jun; 32(6):623-8. PubMed ID: 1890738
[TBL] [Abstract][Full Text] [Related]
6. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
7. Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
Kozbor D; Giallongo A; Sierzega ME; Konopka JB; Witte ON; Showe LC; Croce CM
Nature; 1986 Jan 23-29; 319(6051):331-3. PubMed ID: 3455750
[TBL] [Abstract][Full Text] [Related]
8. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
[TBL] [Abstract][Full Text] [Related]
9. p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
Brusa G; Benvenuti M; Mazzacurati L; Mancini M; Pattacini L; Martinelli G; Barbieri E; Greenberger JS; Baccarani M; Santucci MA
Haematologica; 2003 Jun; 88(6):622-30. PubMed ID: 12801837
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
11. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
Campbell ML; Li W; Arlinghaus RB
Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
[TBL] [Abstract][Full Text] [Related]
12. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.
Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD
Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of the BCR gene product.
Timmons MS; Witte ON
Oncogene; 1989 May; 4(5):559-67. PubMed ID: 2657572
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of chronic myelogenous leukaemia.
Ankathil R; Nair MK
Natl Med J India; 1992; 5(5):219-22. PubMed ID: 1302582
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
17. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
18. Mosaicicm in bcr-abl protein expression in B cells in chronic myelogenous leukemia.
Weissinger EM; Thalmeier K; Dull T; Grammer C; Kempkes B; Brielmeier M; Schumm M; Kolb HJ
Int J Cancer; 1996 Nov; 68(5):577-82. PubMed ID: 8938137
[TBL] [Abstract][Full Text] [Related]
19. Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.
Konopka JB; Clark S; McLaughlin J; Nitta M; Kato Y; Strife A; Clarkson B; Witte ON
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4049-52. PubMed ID: 3012546
[TBL] [Abstract][Full Text] [Related]
20. bcr rearrangement and C-abl gene expression in Ph1-positive hybrid acute leukemia with simultaneous proliferation of lymphoid and myeloid blasts.
Okabe M; Oita M; Kunieda Y; Matsuura J; Sakurada K; Matsushima S; Kakinuma M; Miyazaki T
Blut; 1989 May; 58(5):241-6. PubMed ID: 2655744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
